Related Experiment Video
Updated: Apr 26, 2026
07:17
Single Port Donor Nephrectomy
Published on: March 12, 2011
56.1K
Current status of robotic laparoendoscopic single-site partial nephrectomy
Christos Komninos1, Patrick Tuliao, Koon Ho Rha
1Department of Urology and Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea; Department of Urology, General Hospital of Nikaia "St. Panteleimon", Athens, Greece.
Summary
Robotic laparoendoscopic single-site partial nephrectomy offers cosmetic benefits but has limitations. Current evidence suggests it is feasible but inferior to conventional methods, especially regarding warm ischemia time.
Area of Science:
- Urology
- Minimally Invasive Surgery
- Robotic Surgery
Background:
- Robotic laparoendoscopic single-site partial nephrectomy (R-LESS PN) aims to enhance cosmetic outcomes in minimally invasive procedures.
- The clinical efficacy and limitations of R-LESS PN require further investigation.
Purpose of the Study:
- To review contemporary evidence on the outcomes of robotic laparoendoscopic single-site partial nephrectomy.
- To examine the feasibility, cosmetic results, and potential drawbacks of this novel surgical technique.
Main Methods:
- A systematic literature search was conducted across PubMed, Scopus, and Web of Science databases (2008-2014).
- The review adhered to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
- Data from case reports and retrospective studies were analyzed.
Main Results:
- R-LESS PN is a feasible procedure with acceptable operative times, good cosmetic results, and reduced postoperative pain.
- However, studies indicate it is inferior to conventional approaches, particularly concerning warm ischemia time.
- Current single-site robotic platforms present challenges for surgeons, increasing complexity.
Conclusions:
- Further advancements in robotic platforms and more extensive research are necessary to overcome current limitations.
- R-LESS PN may be suitable for select patients with small, uncomplicated tumors but should not be universally applied.
